Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
Clinical trial NCT07616427 · RECRUITING
Trial details
- NCT number
- NCT07616427
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2028-05-20
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.